0.68 - 0.75
0.33 - 0.86
12.80M / 4.66M (Avg.)
35.00 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
39.61%
Revenue growth above 1.5x 0425.HK's 9.48%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
17.91%
Gross profit growth above 1.5x 0425.HK's 0.74%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
66.33%
Positive EBIT growth while 0425.HK is negative. John Neff might see a substantial edge in operational management.
66.33%
Positive operating income growth while 0425.HK is negative. John Neff might view this as a competitive edge in operations.
-47.50%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-11.19%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-47.67%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-40.81%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
33.34%
Positive OCF growth while 0425.HK is negative. John Neff would see this as a clear operational advantage vs. the competitor.
22.09%
Positive FCF growth while 0425.HK is negative. John Neff would see a strong competitive edge in net cash generation.
30.51%
10Y revenue/share CAGR under 50% of 0425.HK's 452.89%. Michael Burry would suspect a lasting competitive disadvantage.
-1.91%
Negative 5Y CAGR while 0425.HK stands at 106.32%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
16.37%
3Y revenue/share CAGR under 50% of 0425.HK's 50.02%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-267.39%
Negative 10Y OCF/share CAGR while 0425.HK stands at 234.64%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-307.51%
Negative 5Y OCF/share CAGR while 0425.HK is at 168.79%. Joel Greenblatt would question the firm’s operational model or cost structure.
34.33%
3Y OCF/share CAGR 1.25-1.5x 0425.HK's 27.65%. Bruce Berkowitz might see if strategic cost controls or product mix drove recent gains.
135.80%
Net income/share CAGR at 75-90% of 0425.HK's 173.03%. Bill Ackman would press for strategic moves to boost long-term earnings.
97.13%
5Y net income/share CAGR above 1.5x 0425.HK's 36.50%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
-59.63%
Negative 3Y CAGR while 0425.HK is 0.32%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
418.24%
10Y equity/share CAGR above 1.5x 0425.HK's 233.22%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
52.20%
5Y equity/share CAGR at 75-90% of 0425.HK's 68.60%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.
23.32%
3Y equity/share CAGR at 50-75% of 0425.HK's 38.23%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
-100.00%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2.76%
AR growth is negative/stable vs. 0425.HK's 11.83%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
-3.93%
Inventory is declining while 0425.HK stands at 6.30%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
5.51%
Similar asset growth to 0425.HK's 5.80%. Walter Schloss finds parallel expansions or investment rates.
69.47%
BV/share growth above 1.5x 0425.HK's 6.18%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-22.54%
We’re deleveraging while 0425.HK stands at 0.08%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
97.36%
R&D growth drastically higher vs. 0425.HK's 26.97%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
9.83%
SG&A declining or stable vs. 0425.HK's 23.58%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.